Topics

NICE Approves Maintenance Rucaparib for Relapsed Ovarian Cancer

11:43 EDT 11 Oct 2019 | OncLive

The UK’s National Institute for Health and Care Excellence has approved rucaparib for the maintenance treatment of patients with relapsed ovarian, fallopian tube, or peritoneal cancer that has responded to platinum-based chemotherapy.

Original Article: NICE Approves Maintenance Rucaparib for Relapsed Ovarian Cancer

NEXT ARTICLE

More From BioPortfolio on "NICE Approves Maintenance Rucaparib for Relapsed Ovarian Cancer"

Quick Search

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...